Basics Fulcrum Therapeutics, Inc. IPO Date: July 15, 2019 Sector: Healthcare Industry: Biotech Market Cap: $481.65M Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 3.94% Avg Daily Range (30 D): $0.37 | 3.94% Avg Daily Range (90 D): $0.28 | 3.28% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): .75M Avg Daily Volume (90 D): .53M Trade Size Avg Trade Size (Sh.): 103 Avg Trade Size (Sh.) (30 D): 75 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 683 Avg Inst. Trade: $1.52M Avg Inst. Trade (30 D): $.9M Avg Inst. Trade (90 D): $1.23M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.59M Avg Closing Trade (30 D): $.87M Avg Closing Trade (90 D): $1.51M Avg Closing Volume: 180.33K     News Dec 6, 2025 @ 10:30 PM Fulcrum Therapeutics Announces Positive Initial Re... Source: Fulcrum Therapeutics Nov 19, 2025 @ 1:00 PM Datanomix and Fulcrum Modernize Manufacturing Tech... Source: Greg Mchale And Sunny Han Oct 10, 2025 @ 8:30 PM Fulcrum Therapeutics Reports Inducement Grants Und... Source: Kevin Gardner Sep 12, 2025 @ 8:30 PM Fulcrum Therapeutics Reports Inducement Grants Und... Source: Kevin Gardner Feb 7, 2025 @ 9:30 PM Fulcrum Therapeutics Reports Inducement Grants Und... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.28 $-.28 $-.27 Diluted EPS $-.28 $-.28 $-.27 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -17.3M $ -17.66M $ -16.57M Operating Income / Loss $ -19.82M $ -20.4M $ -19.43M Cost of Revenue $ $ $ Net Cash Flow $ -15.62M $ M $ -14.42M PE Ratio